Anavex Life Sciences
AVXL
#8658
Rank
NZ$0.39 B
Marketcap
NZ$4.29
Share price
-2.75%
Change (1 day)
-80.69%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -NZ$68.28 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. , an increase over its 2024 earnings that were of -NZ$89.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$69.17 Million-22.43%
2024 -NZ$89.17 Million14.77%
2023 -NZ$77.7 Million-17.49%
2022 -NZ$94.17 Million22.96%
2021 -NZ$76.58 Million35.36%
2020 -NZ$56.58 Million12.65%
2019 -NZ$50.22 Million29.09%
2018 -NZ$38.91 Million36.33%
2017 -NZ$28.54 Million17.11%
2016 -NZ$24.37 Million20.91%
2015 -NZ$20.16 Million-6.29%
2014 -NZ$21.51 Million337.28%
2013 -NZ$4.92 Million
2008 -NZ$9.1 Million106.01%
2007 -NZ$4.42 Million8848.98%
2006 -NZ$0.05 Million-79.99%
2005 -NZ$0.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$0.32 B-576.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
-NZ$14.22 Million-79.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$10.8 Million-84.39%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.79 Billion 1,035.69%๐Ÿ‡บ๐Ÿ‡ธ USA